反応式
[CH3:1][O:2][C:3]([C:5]1[CH:6]=[C:7]2[C:12](=[CH:13][CH:14]=1)[CH:11]=[C:10](C(O)=O)[CH:9]=[CH:8]2)=[O:4].CC[N:20](CC)CC.C1C=CC(P(N=[N+]=[N-])(C2C=CC=CC=2)=O)=CC=1.[C:42]([O-:45])(O)=[O:43].[Na+].[CH3:47][C:48](O)([CH3:50])[CH3:49]>>[C:48]([O:45][C:42]([NH:20][C:10]1[CH:11]=[C:12]2[C:7](=[CH:8][CH:9]=1)[CH:6]=[C:5]([C:3]([O:2][CH3:1])=[O:4])[CH:14]=[CH:13]2)=[O:43])([CH3:50])([CH3:49])[CH3:47]参加物
実験手順
A suspension of 6-(methoxycarbonyl)-2-naphthoic acid [J. Med. Chem., 2004, 47, 303-324] (146) (1.21 g, 5.26 mmol) in dry t-BuOH (20 mL) containing powdered molecular sieves (1 g) was treated with Et3N (0.88 mL, 6.31 mmol) and stud under N2 at room temperature for 30 min. DPPA (1.25 mL, 5.80 mmol) was added and the mixture was sired at reflux for 7 h, then cooled and poured into dilute aqueous NaHCO3. The resting solid was purified by chromatography on silica gel, eluting with CH2Cl2, followed by trituration with iPr2O and recrystallization from EtOAc to give methyl 6-[(tert-butoxycarbonyl)amino]-2-naphthoate (147) (1.24 g, 78%) as a white solid: mp 178-180° C.; 1H NMR [(CD3)2SO] δ 9.76 (s, 1H), 8.51 (s, 1H), 8.19 (s, 1H), 8.02 (d, J=9.0 Hz, 1H), 7.90 (dd, J=8.6, 1.6 Hz, 1H), 7.86 (d, J=8.7 Hz, 1H), 7.59 (dd, J=8.9, 2.1 Hz, 1H), 3.89 (s, 3H), 1.52 (s, 9H). Anal. (C17H19NO4) C, H, N.
後処理
- additioncontaining
- temperatureat reflux for 7 h
- temperaturecooled
- customThe resting solid was purified by chromatography on silica gel
- washeluting with CH2Cl2
- customfollowed by trituration with iPr2O and recrystallization from EtOAc
出典と根拠
- ORDレコード
- ord-bd1c72b315d944a6b7df28551dc9fefd
- 出典データセット
- uspto-grants-2010_05
- 特許番号
- US07718688B2
関連ノート
読み込み中…